Shaheen, R M <br/><br/>
Antiangiogenic therapy targeting the tyrosine kinase receptor for vascular endothelial growth factor receptor inhibits the growth of colon cancer liver metastasis and induces tumor and endothelial cell apoptosis.  [electronic resource] 

 -  Cancer research  Nov 1999 
 - 5412-6 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0008-5472 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Apoptosis<br/>Colonic Neoplasms--drug therapy<br/>Endothelium--drug effects<br/>Fluorescent Antibody Technique<br/>In Situ Nick-End Labeling<br/>Indoles--pharmacology<br/>Liver Neoplasms--drug therapy<br/>Male<br/>Mice<br/>Mice, Inbred BALB C<br/>Neovascularization, Pathologic--drug therapy<br/>Pyrroles--pharmacology<br/>Random Allocation<br/>Receptor Protein-Tyrosine Kinases--drug effects<br/>Receptors, Growth Factor--drug effects<br/>Receptors, Vascular Endothelial Growth Factor<br/>Tumor Cells, Cultured